Literature DB >> 12194500

Dynamics of extracellular dopamine in the acute and chronic actions of cocaine.

Charles W Bradberry1.   

Abstract

Cocaine amplifies dopaminergic neurotransmission via blockade of presynaptic neuronal uptake. This action is believed to be a crucial component of cocaine's ability to exert its reinforcing effects. This review will provide a brief overview of extracellular dopamine dynamics associated with cocaine. The acute effects of cocaine reviewed include comparison of intravenous and intraperitoneal routes of administration to better understand how fast and slow routes (e.g., crack and intranasal) differ in their pharmacokinetics and neurochemical effects and how those differences relate to differences in abuse potential. Changes in the acute effects of cocaine within a session have been examined in neurochemical studies of acute tolerance to self-administered cocaine in rhesus monkeys, and the potential impact of that tolerance to patterns of use is discussed. Between-session sensitization of the dopaminergic response to cocaine is reviewed, and data indicating this also occurs in primates have been obtained in self-administering rhesus monkeys, demonstrating neurochemical sensitization in a primate species. The important question of whether cocaine-associated environmental cues elicit conditioned increases in dopamine release has also been examined in the rhesus monkey, with results indicating that, unlike rats, nonhuman primates do not show conditioned increases in dopamine release.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12194500     DOI: 10.1177/107385840200800407

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  8 in total

1.  Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.

Authors:  S Tai; W S Hyatt; C Gu; L N Franks; T Vasiljevik; L K Brents; P L Prather; W E Fantegrossi
Journal:  Pharmacol Res       Date:  2015-09-08       Impact factor: 7.658

2.  Quantification of Synthetic Cathinones in Rat Brain Using HILIC-ESI-MS/MS.

Authors:  Jacob R Peters; Robert Keasling; Stacy D Brown; Brooks B Pond
Journal:  J Anal Toxicol       Date:  2016-07-29       Impact factor: 3.367

3.  An in vivo microdialysis assessment of concurrent MDMA and cocaine administration in Sprague-Dawley rats.

Authors:  John J Panos; Lisa E Baker
Journal:  Psychopharmacology (Berl)       Date:  2010-01-30       Impact factor: 4.530

4.  Striatal regulation of ΔFosB, FosB, and cFos during cocaine self-administration and withdrawal.

Authors:  Erin B Larson; Fatih Akkentli; Scott Edwards; Danielle L Graham; Diana L Simmons; Imran N Alibhai; Eric J Nestler; David W Self
Journal:  J Neurochem       Date:  2010-08-03       Impact factor: 5.372

5.  Smokers versus snorters: do treatment outcomes differ according to route of cocaine administration?

Authors:  Brian D Kiluk; Theresa A Babuscio; Charla Nich; Kathleen M Carroll
Journal:  Exp Clin Psychopharmacol       Date:  2013-12       Impact factor: 3.157

6.  Evidence of temporal cortical dysfunction in rhesus monkeys following chronic cocaine self-administration.

Authors:  S Liu; R P Heitz; A R Sampson; W Zhang; C W Bradberry
Journal:  Cereb Cortex       Date:  2007-12-19       Impact factor: 5.357

7.  Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology.

Authors:  Christopher T Smith; Jessica Weafer; Ronald L Cowan; Robert M Kessler; Abraham A Palmer; Harriet de Wit; David H Zald
Journal:  J Psychopharmacol       Date:  2016-02-15       Impact factor: 4.153

8.  Current perspectives on the neurobiology of drug addiction: a focus on genetics and factors regulating gene expression.

Authors:  Jhodie R Duncan
Journal:  ISRN Neurol       Date:  2012-10-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.